Population modeling of the relationship between the pharmacokinetics of the oral thrombin inhibitor dabigatran etexilate and coagulation biomarkers in patients with non-valvular atrial fibrillation from the RE-LY trial - Schäftlein, A; Maas, H; Reilly, PA
Accessed February 19, 2015.